๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Diabetic hepatosclerosis: A novel entity or a rare form of nonalcoholic fatty liver disease?

โœ Scribed by Michael Mendoza; Zobair Younossi


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
61 KB
Volume
44
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


Objective: This study sought to characterize a noncirrhotic form of hepatic sinusoidal fibrosis in patients with long-standing diabetes mellitus (DM) who underwent liver biopsy. The authors suggest that diabetic hepatosclerosis is distinct from other hepatic manifestations of DM. Methods: Clinical records, detailed light microscopy results, and immunohistochemical preparations of twelve diabetic patients presenting with characteristic histologic findings were reviewed. Liver biopsy slides were evaluated for the degree of perisinusoidal, perivenular, and portal fibrosis, along with other histologic findings. When available, unstained biopsy sections were used for additional immunohistochemical analyses. Medical records were examined for relevant clinical data. Patients were chosen from Saint Louis University School of Medicine and the Armed Forces Institute of Pathology. Results: All patients presented with a long-standing history of DM and most had evidence of microvascular complications resulting in end-organ damage. Alkaline phosphatase elevation was common. Immunohistochemical staining of liver biopsies showed basement membrane components in a perisinusoidal distribution. Hematoxylin-eosin and trichrome staining of the biopsies revealed dense perisinusoidal fibrosis while lacking other features commonly seen in non-alcoholic steatohepatitis (NASH). Conclusions: These findings suggest a form of diabetic microangiopathy affecting the liver, described as diabetic hepatosclerosis. Further investigation must be done to understand the pathogenesis and clinical significance of this novel entity.


๐Ÿ“œ SIMILAR VOLUMES


In vivo assessment of liver cell apoptos
โœ Anna Wieckowska; Nizar N. Zein; Lisa M. Yerian; A. Rocio Lopez; Arthur J. McCull ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 344 KB ๐Ÿ‘ 2 views

In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only reliable way to differentiate simple steatosis from nonalcoholic steatohepatitis (NASH). Noninvasive methods are urgently needed. Increasing evidence suggests hepatocyte apoptosis is a key mediator of liver in

Risk of severe liver disease in nonalcoh
โœ Anna Ludovica Fracanzani; Luca Valenti; Elisabetta Bugianesi; Marco Andreoletti; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB ๐Ÿ‘ 1 views

It is uncertain whether patients with nonalcoholic fatty liver disease (NAFLD) and normal alanine aminotransferase (ALT) have a milder disease and should undergo liver biopsy. We reviewed the histological data of 458 Italian patients with NAFLD in whom liver biopsy was indicated by altered liver enz

The natural history of nonalcoholic fatt
โœ Neeraj Bhala; Paul Angulo; David van der Poorten; Eric Lee; Jason M. Hui; Giorgi ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 245 KB

Information on the long-term prognosis of nonalcoholic fatty liver disease (NAFLD) is limited. We sought to describe the long-term morbidity and mortality of patients with NAFLD with advanced fibrosis or cirrhosis by prospectively studying 247 such patients from four international centers (in Austra